Antifungal Drugs Market 2017 Trend, Growth and Forecast to 2021
ReportsWeb.com published “Antifungal Drugs Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
(EMAILWIRE.COM, May 16, 2017 ) Antifungal drugs are chemical compounds used to kill or inhibit the growth of fungi. These drugs act by various mechanisms such as the inhibition of cell division, the inhibition of cell wall formation, and cell membrane disruption.
Publisher's analysts forecast the global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021.
+For more information about this report: http://www.reportsweb.com/global-antifungal-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Antifungal Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Pfizer
- Merck
- Astellas Pharma
- Novartis
- Johnson & Johnson
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001685330/sample .
Other prominent vendors
- Allergan
- Almirall
- Amgen
- Aqua Pharmaceuticals
- AstraZeneca
- Bayer
- Bristol-Myers Squibb
- Celgene
- Dermira
- Elorac
- F. Hoffmann-La Roche
- Galderma
- Genentech
- GlaxoSmithKline
- Hexima
- Hisamitsu Pharmaceutical
- Incyte
- Mayne Pharma
- MediQuest Therapeutics
- Meiji Seika Pharma
- Merz Pharmaceuticals
- Moberg Pharma
- Mylan Pharmaceuticals
- NanoBio
- NovaBiotics
- Novan
- Nuvo Research
- Polichem
- Promius Pharma
- Sanofi
- Seren Pharmaceuticals
- Sun Pharma
- Taro
- Teva Pharmaceutical
- Theravance Biopharma
- Topica Pharmaceuticals
- Viamet Pharmaceuticals
Market driver
- Rising popularity of OTC antifungal drugs for dermal infections
- For a full, detailed list, view our report
Market challenge
- Antifungal drug resistance
- For a full, detailed list, view our report
Market trend
- Increased funding for antifungal research
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001685330/buying .
Publisher's analysts forecast the global antifungal drugs market to grow at a CAGR of 3.20% during the period 2017-2021.
+For more information about this report: http://www.reportsweb.com/global-antifungal-drugs-market-2017-2021 .
Covered in this report
The report covers the present scenario and the growth prospects of the global antifungal drugs market for 2017-2021. To calculate the market size, the report considers revenue generated from the sales of branded, generics and OTC drugs used for the treatment and prevention of various fungal infections. The report also considers the revenue to be generated from the sales of drugs that are expected to be launched in the market along with the decline in revenue from the patent expiries of the marketed drugs during the forecast period.
The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA
Publisher's report, Global Antifungal Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- Pfizer
- Merck
- Astellas Pharma
- Novartis
- Johnson & Johnson
Request Sample Copy at http://www.reportsweb.com/inquiry&RW0001685330/sample .
Other prominent vendors
- Allergan
- Almirall
- Amgen
- Aqua Pharmaceuticals
- AstraZeneca
- Bayer
- Bristol-Myers Squibb
- Celgene
- Dermira
- Elorac
- F. Hoffmann-La Roche
- Galderma
- Genentech
- GlaxoSmithKline
- Hexima
- Hisamitsu Pharmaceutical
- Incyte
- Mayne Pharma
- MediQuest Therapeutics
- Meiji Seika Pharma
- Merz Pharmaceuticals
- Moberg Pharma
- Mylan Pharmaceuticals
- NanoBio
- NovaBiotics
- Novan
- Nuvo Research
- Polichem
- Promius Pharma
- Sanofi
- Seren Pharmaceuticals
- Sun Pharma
- Taro
- Teva Pharmaceutical
- Theravance Biopharma
- Topica Pharmaceuticals
- Viamet Pharmaceuticals
Market driver
- Rising popularity of OTC antifungal drugs for dermal infections
- For a full, detailed list, view our report
Market challenge
- Antifungal drug resistance
- For a full, detailed list, view our report
Market trend
- Increased funding for antifungal research
- For a full, detailed list, view our report
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001685330/buying .
Contact Information:
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
ReportsWeb.com
Priya Sisodia
Tel: +1-646-491-9876
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results